{
  "company": {
    "name": "Enterome",
    "website": "https://enterome.com/",
    "record": "https://startuphistory.org/c/enterome.com"
  },
  "status": null,
  "history_since": "2011-11-15T14:18:14.000Z",
  "baseline": {
    "snapshot_id": "0bb034f06275d0862d2dc5bd5e1a0da6588d519bd0c2f96d2f0de689f9ff6133",
    "observed_at": "2011-11-15T14:18:14.000Z",
    "headline": "Enterome is Paris-based Bioscience Company co-founded by an experienced management team & world’s leading experts in human metagenomic field.",
    "description": "Enterome is Paris-based Bioscience Company co-founded by an experienced management team & world’s leading experts in human metagenomic field.",
    "evidence": "https://web.archive.org/web/20111115141814/http://www.enterome.com:80/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T13:59:20.905Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2014-11-09T16:17:59.000Z",
      "variants": [
        {
          "headline": "Enterome is Paris-based Bioscience Company co-founded by an experienced management team & world’s leading experts in human metagenomic field.",
          "subhead": "Enterome is Paris-based Bioscience Company co-founded by an experienced management team & world’s leading experts in human metagenomic field.",
          "observed_at": "2011-11-15T14:18:14.000Z",
          "evidence": "https://web.archive.org/web/20111115141814/http://www.enterome.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Enterome | Bioscience",
          "subhead": null,
          "observed_at": "2014-11-09T16:17:59.000Z",
          "evidence": "https://web.archive.org/web/20141109161759/http://www.enterome.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Enterome | Bioscience",
      "subhead": null,
      "from": "2011-11-15T14:18:14.000Z",
      "to": "2014-11-09T16:17:59.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20141109161759/http://www.enterome.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2011-11-15T14:18:14.000Z",
          "to": "2014-11-09T16:17:59.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2016-02-01T04:45:06.000Z",
      "variants": [
        {
          "headline": "ACCESS PRESS ROOM",
          "subhead": null,
          "observed_at": "2016-02-01T04:45:06.000Z",
          "evidence": "https://web.archive.org/web/20160201044506/http://www.enterome.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "ACCESS PRESS ROOM",
      "subhead": null,
      "from": "2016-02-01T04:45:06.000Z",
      "to": "2016-02-01T04:45:06.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20160201044506/http://www.enterome.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2016-02-01T04:45:06.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2019-01-10T22:31:47.000Z",
      "variants": [
        {
          "headline": "ENTEROME TRANSLATE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIVER INNOVATIVE PERSONALIZED MEDICINE AND IMPROVE PATIENT HEALTH.",
          "subhead": null,
          "observed_at": "2017-07-25T10:39:58.000Z",
          "evidence": "https://web.archive.org/web/20170725103958/http://www.enterome.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ENTEROME’S MISSION: TO IMPROVE PATIENT HEALTH BY TRANSLATING THE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIVER INNOVATIVE MEDICINES.",
          "subhead": null,
          "observed_at": "2019-01-10T22:31:47.000Z",
          "evidence": "https://web.archive.org/web/20190110223147/https://www.enterome.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "ENTEROME’S MISSION: TO IMPROVE PATIENT HEALTH BY TRANSLATING THE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIVER INNOVATIVE MEDICINES.",
      "subhead": null,
      "from": "2017-07-25T10:39:58.000Z",
      "to": "2019-01-10T22:31:47.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20190110223147/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2017-07-25T10:39:58.000Z",
          "to": "2019-01-10T22:31:47.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2020-07-12T16:42:47.000Z",
      "variants": [
        {
          "headline": "ENTEROME IS HARNESSING THE MICROBIOME-IMMUNO-INFLAMMATION AXIS TO CREATE NEXT-GENERATION THERAPEUTICS",
          "subhead": null,
          "observed_at": "2020-07-12T16:42:47.000Z",
          "evidence": "https://web.archive.org/web/20200712164247/https://www.enterome.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "ENTEROME IS HARNESSING THE MICROBIOME-IMMUNO-INFLAMMATION AXIS TO CREATE NEXT-GENERATION THERAPEUTICS",
      "subhead": null,
      "from": "2020-07-12T16:42:47.000Z",
      "to": "2020-07-12T16:42:47.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20200712164247/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2020-07-12T16:42:47.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2022-01-02T02:31:23.000Z",
      "variants": [
        {
          "headline": "Microbiome decoded ∙ Healthcare transformed",
          "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
          "observed_at": "2022-01-02T02:31:23.000Z",
          "evidence": "https://web.archive.org/web/20220102023123/https://www.enterome.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Microbiome decoded ∙ Healthcare transformed",
      "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
      "from": "2022-01-02T02:31:23.000Z",
      "to": "2022-01-02T02:31:23.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20220102023123/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2022-01-02T02:31:23.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T13:59:20.905Z",
      "variants": [
        {
          "headline": "Delivering the promise of cancer immunotherapy",
          "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
          "observed_at": "2023-07-14T03:44:09.000Z",
          "evidence": "https://web.archive.org/web/20230714034409/https://www.enterome.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Delivering the promise of cancer immunotherapy",
          "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
          "observed_at": "2025-01-02T05:09:30.000Z",
          "evidence": "https://web.archive.org/web/20250102050930/https://www.enterome.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Delivering the promise of cancer immunotherapy",
          "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
          "observed_at": "2025-07-26T17:25:55.000Z",
          "evidence": "https://web.archive.org/web/20250726172555/https://www.enterome.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Delivering the promise of cancer immunotherapy",
          "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
          "observed_at": "2026-02-03T09:38:26.000Z",
          "evidence": "https://web.archive.org/web/20260203093826/https://www.enterome.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Delivering the promise of cancer immunotherapy",
          "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
          "observed_at": "2026-07-13T11:27:24.000Z",
          "evidence": "https://web.archive.org/web/20260713112724/https://www.enterome.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Delivering the promise of cancer immunotherapy",
          "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
          "observed_at": "2026-09-12T09:39:56.000Z",
          "evidence": "https://web.archive.org/web/20260912093956/https://www.enterome.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Delivering the promise of cancer immunotherapy",
          "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
          "observed_at": "2026-11-05T13:59:20.905Z",
          "evidence": "https://www.enterome.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Delivering the promise of cancer immunotherapy",
      "subhead": "We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.",
      "from": "2023-07-14T03:44:09.000Z",
      "to": "2026-11-05T13:59:20.905Z",
      "captures": 7,
      "evidence": "https://www.enterome.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2023-07-14T03:44:09.000Z",
          "to": "2026-11-05T13:59:20.905Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-b00022c12b1e1a32a5ccc4650575a124a670dd8ba7e29199a4345c440dd44da2:a049209b12ac7940ea93010bb4a52db557e2f279c9345a52f9cb7099aaae59d8:headline:77c655c7cf8cffea",
      "before_evidence": "https://web.archive.org/web/20160201044506/http://www.enterome.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “ACCESS PRESS ROOM” to “ENTEROME TRANSLATE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIVER INNOVATIVE PERSONALIZED MEDICINE AND IMPROV…”.",
      "between": {
        "from": "2016-02-01T04:45:06.000Z",
        "to": "2017-07-25T10:39:58.000Z"
      },
      "evidence": "https://web.archive.org/web/20170725103958/http://www.enterome.com:80/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-e6bc0f53809bcfc078eb326a1d9fe2a3e402844d36223cad981d059c5d4b76f0:75e450036f0212e93cbd08930384fd650049a99fa9aec467ea056324caa79b95:funding:2580d8eeffb28a2f",
      "before_evidence": "https://web.archive.org/web/20190110223147/https://www.enterome.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “INVESTORS Enterome was established in 2012 and has raised close to €100 million in financing rounds with private equity funds (and strate…”.",
      "between": {
        "from": "2019-01-10T22:31:47.000Z",
        "to": "2020-07-12T16:42:47.000Z"
      },
      "evidence": "https://web.archive.org/web/20200712164247/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 3,
      "id": "page-e6bc0f53809bcfc078eb326a1d9fe2a3e402844d36223cad981d059c5d4b76f0:75e450036f0212e93cbd08930384fd650049a99fa9aec467ea056324caa79b95:headline:b991fda274c877fb",
      "before_evidence": "https://web.archive.org/web/20190110223147/https://www.enterome.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “ENTEROME’S MISSION: TO IMPROVE PATIENT HEALTH BY TRANSLATING THE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIV…” to “ENTEROME IS HARNESSING THE MICROBIOME-IMMUNO-INFLAMMATION AXIS TO CREATE NEXT-GENERATION THERAPEUTICS”.",
      "between": {
        "from": "2019-01-10T22:31:47.000Z",
        "to": "2020-07-12T16:42:47.000Z"
      },
      "evidence": "https://web.archive.org/web/20200712164247/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 4,
      "id": "page-75e450036f0212e93cbd08930384fd650049a99fa9aec467ea056324caa79b95:4b4292a8032e85c29743160c56f771dc34721014d3cb274826332e9bf3c20342:headline:877abc42108df51a",
      "before_evidence": "https://web.archive.org/web/20200712164247/https://www.enterome.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “ENTEROME IS HARNESSING THE MICROBIOME-IMMUNO-INFLAMMATION AXIS TO CREATE NEXT-GENERATION THERAPEUTICS” to “Microbiome decoded ∙ Healthcare transformed”.",
      "between": {
        "from": "2020-07-12T16:42:47.000Z",
        "to": "2022-01-02T02:31:23.000Z"
      },
      "evidence": "https://web.archive.org/web/20220102023123/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 5,
      "id": "page-75e450036f0212e93cbd08930384fd650049a99fa9aec467ea056324caa79b95:4b4292a8032e85c29743160c56f771dc34721014d3cb274826332e9bf3c20342:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20200712164247/https://www.enterome.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2020-07-12T16:42:47.000Z",
        "to": "2022-01-02T02:31:23.000Z"
      },
      "evidence": "https://web.archive.org/web/20220102023123/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 6,
      "id": "classifier-4b4292a8032e85c29743160c56f771dc34721014d3cb274826332e9bf3c20342:6b90c63021e3b4e1e8fa70d91d76fcec82c026c1769d43130d0e015d5aa84a14:repositioning",
      "before_evidence": "https://web.archive.org/web/20220102023123/https://www.enterome.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "repositioning",
      "label": "Messaging",
      "summary": "Changed its homepage headline from “Microbiome decoded ∙ Healthcare transformed” to “Delivering the promise of cancer immunotherapy”.",
      "between": {
        "from": "2022-01-02T02:31:23.000Z",
        "to": "2023-07-14T03:44:09.000Z"
      },
      "evidence": "https://web.archive.org/web/20230714034409/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "basis": "classifier",
      "topic": "https://startuphistory.org/t/repositioned"
    },
    {
      "n": 7,
      "id": "page-6b90c63021e3b4e1e8fa70d91d76fcec82c026c1769d43130d0e015d5aa84a14:63baa30efbc2e97f7d65aee232328255f85e6bf067191dc2b85cf02a0e96bef5:traction:a98e07e521cec1e3",
      "before_evidence": "https://web.archive.org/web/20230714034409/https://www.enterome.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "traction",
      "label": "Traction",
      "summary": "Now claims “200 patients” on its homepage (was “150 patients”).",
      "between": {
        "from": "2023-07-14T03:44:09.000Z",
        "to": "2025-01-02T05:09:30.000Z"
      },
      "evidence": "https://web.archive.org/web/20250102050930/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/grew-traction-claims"
    },
    {
      "n": 8,
      "id": "page-63baa30efbc2e97f7d65aee232328255f85e6bf067191dc2b85cf02a0e96bef5:bb25c9c3d8f0c240b6fa71de8a8b5c906fa49077dbe986e559eb2424e466e341:traction:b6cdf0f4815e26fd",
      "before_evidence": "https://web.archive.org/web/20250102050930/https://www.enterome.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "traction",
      "label": "Traction",
      "summary": "Now claims “240 patients” on its homepage (was “200 patients”).",
      "between": {
        "from": "2025-01-02T05:09:30.000Z",
        "to": "2025-07-26T17:25:55.000Z"
      },
      "evidence": "https://web.archive.org/web/20250726172555/https://www.enterome.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/grew-traction-claims"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Enterome” company record, https://startuphistory.org/c/enterome.com"
}